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A B S T R A C T
A new enteric virus of adult horses, equine coronavirus (ECoV), has recently been recognized. It is
associated with fever, lethargy, anorexia, and less frequently, colic and diarrhea. This enteric virus is
transmitted via the feco-oral route and horses become infected by ingesting fecally contaminated feed
and water. Various outbreaks have been reported since 2010 from Japan, Europe and the USA. While the
clinical signs are fairly non-specific, lymphopenia and neutropenia are often seen. Specific diagnosis is
made by the detection of ECoV in feces by either quantitative real-time PCR, electron microscopy or
antigen-capture ELISA. Supportive treatment is usually required, as most infections are self-limiting.
However, rare complications, such as endotoxemia, septicemia and hyperammonemia-associated
encephalopathy, have been reported, and have been related to the loss of barrier function at the intestinal
mucosa. This review article will focus on the latest information pertaining to the virus, epidemiology,
clinical signs, diagnosis, pathology, treatment and prevention of ECoV infection in adult horses.
© 2017 Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
The Veterinary Journal
journal homepage: www.else vie r .com/ locate / t vj lIntroduction
Equine coronavirus (ECoV) is a newly recognized enteric virus
of adult horses that has been associated with fever, lethargy and
anorexia, as well as colic and diarrhea. Outbreaks have been
reported in Japan, Europe and the USA since 2010. This article
reviews biology, epidemiology, clinical signs, diagnosis, pathology,
treatment and prevention of ECoV infection in horses.
Etiology
Coronaviruses are single-stranded, positive sense, non-seg-
mented, enveloped RNA viruses belonging to the family Corona-
viridae. They are responsible for respiratory, enteric, hepatic and
neurologic disease in mammals and birds (Wege et al., 1982).
Within the Coronaviridae subfamily Coronavirinae, there are four
genera defined on the basis of serological cross-reactivity and
genetic homology: Alphacoronavirus, Betacoronavirus, Deltacoro-
navirus and Gammacoronavirus (Woo et al., 2012). ECoV is classified
within the Betacoronavirus 1 genus, along with human coronavi-
ruses OC43, 4408 and HKU1, bovine coronavirus (BCoV), porcine
hemagglutinating encephalomyelitis virus, canine respiratory* Corresponding author.
E-mail address: npusterla@ucdavis.edu (N. Pusterla).
https://doi.org/10.1016/j.tvjl.2017.11.004
1090-0233/© 2017 Elsevier Ltd. All rights reserved.coronavirus, mouse hepatitis virus, bubaline coronavirus and
sialodacryoadenitis rat coronavirus (Zhang et al., 2007). Corona-
viruses have helical capsids made up of the nucleocapsid protein
complexed with the genomic RNA. In the envelope, the spike
protein trimerises to form peplomers, giving the virion its corona
or crown-like morphology. ECoV also has smaller spikes on the
membrane made from the hemagglutinin esterase protein. In
addition, two structural proteins, designated the membrane and
small membrane proteins, of the virion are fully trans-membra-
nous (Weiss and Leibowitz, 2011). Full genome sequences are
available for four ECoV isolates, one from the USA and three from
Japan (Zhang et al., 2007; Nemoto et al., 2015a). The three recent
isolates from Japan were closely related to the isolate from North
Carolina (NC99), with sequence homology ranging from 98.2 to
98.7% (Nemoto et al., 2015a).
Epidemiology
Since 2010 (this is the first full-year data set after ECoV real-
time-quantitative PCR (qPCR) testing was introduced by molecular
diagnostic laboratories in December 2009), the compiled data from
three veterinary diagnostic laboratories in the USA (IDEXX
Laboratories, West Sacramento, USA; Animal Health Diagnostic
Center, AHDC, Cornell University, Ithaca, USA; Real-time PCR
Research and Diagnostics Core Facility, University of California,
Davis, USA) shows that the total yearly number of ECoV qPCR
Fig. 1. Relative proportion of equine coronavirus real-time quantitative PCR
positive (black) and negative (white) samples by states submitted from January
2012 to December 2016 to three commercial veterinary diagnostic laboratories in
the USA (IDEXX Laboratories, West Sacramento; Animal Health Diagnostic Center,
Cornell University, Ithaca; Real-time PCR Research and Diagnostics Core Facility,
University of California, Davis).
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positive cases has remained within the 2 to 6% range. The increase
in overall number is driven by increased awareness and testing.
The number of ECoV qPCR-positive cases is higher during the
colder months of the year (October to April), similar to the seasonal
disease pattern seen with BCoV. Samples from horses testing
positive for ECoV by qPCR have come from all states of the USA
except Hawaii and Alaska (Fig. 1).
Since 2010, clinical ECoV infections have predominantly been
reported in adult horses (Oue et al., 2011, 2013; Pusterla et al., 2013;
Miszczak et al., 2014; Fielding et al., 2015). As an example, in 2014,
the age distribution of confirmed ECoV infections was 20.5% in
foals (age 0–6 months), 25.3% in horses aged 6 months to 5 years
and 54.2% in horses older than 5 years. Foals from Central Kentucky
with clinical gastrointestinal disease were found to be only positive
for ECoV if other co-infections were present (e.g. rotavirus or
Clostridium perfringens) with the detection frequency of ECoV by
qPCR being similar between healthy and clinically affected foals
(Slovis et al., 2014). This is in sharp contrast to a similar study
performed in Japan (Nemoto et al., 2015b), showing that ECoV was
not detected in rectal swabs from 307 diarrheic foals in the Hidaka
district of Hokkaido. Adult horses with clinical signs experience a
mono-infection with ECoV (Pusterla et al., 2013). The closely-
related BCoV also causes enteric disease in adult cows and mild
respiratory disease in calves (Saif et al., 1986; Tsunemitsu et al.,
1999; Tråvén et al., 2001; O’Neill et al., 2014). ECoV outbreaks in
adult horses have been reported in riding, racing and show horses,
and less frequently in breeding animals. It is speculated that given
the lack of large numbers of documented clinical cases at larger
breeding farms, one hypothesis is that ECoV circulates between
young and adult horses, conferring protection against clinical
disease in adult horses.
A recent seroepidemiological study performed on 5250 healthy
adult horses from 18 states in the USA showed various risk factors
associated with ECoV seropositivity (Kooijman et al., 2017). The
Midwest region displayed the highest odds ratio (OR) of
seropositivity in horses (OR = 1.80). Furthermore, draft horses
showed the highest odds ratio of seroprevalence of the breeds
tested (OR = 1.95), while Thoroughbreds had the lowest odds ratio
of seroprevalence (OR = 0.48). Ranch/farm and breeding horses
displayed the highest odds ratio of seroprevalence (OR = 1.30,
OR = 1.60). The authors of this study speculated that factors
contributing to the higher ECoV seroprevalence in the Midwest
could be related to the higher numbers of ECoV seropositive draft
horses used for farm/ranch work and breeding in that region.While the determined risk factors highlighted by Kooijman et al.
(2017) are very specific to the studied horse population, it is
interesting to notice that draft horses have a higher infection rate
compared to other breeds. This parallels with the first ECoV cases
reported from Japan in racing draft horses (Oue et al., 2011, 2013).
A recent experimental study in which young Japanese draft
horses were infected by naso-esophageal intubation using feces
from a confirmed ECoV infected horse, supports a feco-oral route of
transmission (Nemoto et al. 2014). Seventy-five percent of the
horses developed clinical signs compatible with ECoV infection
and ECoV was detected in their feces using qPCR. Nasal secretions
were ECoV qPCR-positive during the time of peak fecal shedding.
However, it could not be determined if this was due to nasal
replication and shedding of the virus, from environmental
contamination from the feces, or from both sources.
In a study of young and adult horses with either respiratory or
gastrointestinal signs in France, 11/395 (2.8%) fecal samples and 1/
200 (0.5%) nasal swabs were positive for ECoV by qPCR (Miszczak
et al., 2014). Out of 2437 nasal secretions from horses with fever
and respiratory signs tested for common respiratory viruses,
17 horses (0.7%) tested qPCR-positive for ECoV (Pusterla et al.,
2015). Five of 315 (1.6%) rectal swabs and 0/306 nasal swabs from
apparently healthy horses in Saudi Arabia and Oman were positive
for ECoV by PCR (Hemida et al., 2017). Collectively, these studies
show that ECoV is infrequently detected in nasal secretions from
healthy horses and horses with respiratory infections.
In field outbreaks, the morbidity rates for ECoV infections have
been reported to range from 10 to 83% (Oue et al., 2011, 2013;
Pusterla et al., 2013; Fielding et al., 2015). Fatalities are rare, but
have been associated with disruption of the gastrointestinal
mucosal barrier leading to septicemia, endotoxemia and hyper-
ammonemia-associated encephalopathy (Fielding et al., 2015;
Giannitti et al., 2015). The incubation period for ECoV is short and
clinical disease develops between 48 to 72 h after either natural
exposure or experimental infection (Nemoto et al., 2014; Fielding
et al., 2015). Clinical signs are present for a few days to 1 week and
generally resolve with minimal supportive care.
Under natural conditions, fecal shedding of ECoV by qPCR has
been reported to range from 3 to 25 days (Pusterla et al., 2013;
Fielding et al., 2015; L.D. Mittel, unpublished data). It is not known
how long ECoV persists in the environment and, if so, whether this
can act as a source of infection. Human coronaviruses, such as
severe acute respiratory syndrome (SARS)-CoV, have been shown
to persist up to 2 days in waste water and dechlorinated tap water,
3 days in feces and 17 days in urine at room temperature (Wang
et al., 2005). Survival may be longer at lower temperatures; the
virus persists for up to 14 days in waste water and at least 17 days in
feces or urine at 4 C (Wang et al., 2005). Greater survival and
viability of ECoV and BCoV in colder weather is one possible
explanation for the apparent higher prevalence of virus-positive
fecal samples and clinical disease during cooler weather.
Clinical presentation
When clinical information was pooled from 20 outbreaks of
ECoV during the period of November 2011 to March 2017, 130/472
(27.5%) horses presented with clinical signs (Pusterla et al., 2013; N.
Pusterla, unpublished data). The most frequent clinical signs
reported were anorexia (97%), lethargy (88%) and fever (83%). Peak
rectal temperature of febrile horses ranged from 38.6 to 41.0 C
(median 39.9 C). Changes in fecal character, ranging from soft-
formed to watery consistency, and colic were observed in 23% and
19% of clinically affected horses, respectively. Systemic signs
(anorexia and fever) preceded gastrointestinal signs. Lethargy,
anorexia and pyrexia were also the main clinical signs in recent
outbreaks in adult draft horses from Japan, while specific
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horses (Oue et al., 2011, 2013). Signs of encephalopathy, including
circling, head pressing, ataxia, proprioceptive deficits, nystagmus,
recumbency and seizures, have been reported in 3% of clinically
infected horses (Pusterla et al., 2013; Fielding et al., 2015). Fielding
et al. (2015) reported a case that had severe hyperammonemia
(677 mmol/L; reference  60 mmol/L) and died after exhibiting
encephalopathic signs. Hyperammonemia associated with ECoV
infection may be caused by increased ammonia production within
or absorption from the gastrointestinal tract as a consequence of
gastrointestinal barrier breakdown. Enteric ammonia production
could increase as a result of bacterial microbiome changes
associated with ECoV infection.
During various outbreaks, 4–83% of horses have remained
asymptomatic (inapparent infection), even when ECoV was
detected in their feces (Pusterla et al. 2013; N. Pusterla,
unpublished data). The wide range of inapparent infections likely
relates to a combination of viral, host and environmental factors
modulating disease expression.
Diagnostic evaluation
A diagnosis of ECoV infection relies on the presence of clinical
signs compatible with ECoV infection, hematological changes
(neutropenia and/or lymphopenia), the exclusion of other infec-
tious agents and the detection of ECoV in feces.
The majority of horses infected with ECoV develop leukopenia
due to neutropenia and/or lymphopenia. In 37 clinical cases of
ECoV infection, the total nucleated cell count ranged from 520 to
6890/mL (median 3210/mL; reference interval 5000–11,600/mL;
Fig. 2). The blood white cell count showed leukopenia in 73%,
neutropenia in 65% and lymphopenia in 81% of the horses. The
neutrophil and lymphocyte counts in these horses ranged from
250 to 4814/mL (median 1643/mL; reference interval 2600–6800/
mL) and 80–3510/mL (median 950/mL; reference interval 1600–
5800/mL), respectively. Some animals showed less consistent
hematological abnormalities, including the presence of band
neutrophils and shifts in monocyte counts (usually changing fromFig. 2. Hematological findings in 37 adult horses with laboratory confirmation of
equine coronavirus infection. The results are expressed as individual values, with
the median indicated by a horizontal bar.a low or a normal count to a high-normal or rebound monocytosis).
If no complications associated with the disruption of the
gastrointestinal barrier occured, the hematological abnormalities
generally resolved in 5–7 days. However, a normal blood cell count
and white cell differential did not rule out an ECoV infection, as
rather 11% of ECoV infected horses showed no hematological
abnormalities.
Usually, biochemical parameters are unremarkable, but eleva-
tion of total and indirect bilirubin due to partial or complete
anorexia, electrolyte changes consistent with enterocolitis, tran-
sient elevation of liver enzymes and renal parameters suggesting
pre-renal azotemia have been observed in some cases. Blood
ammonia should be measured in any horse with signs of
encephalopathy and suspected ECoV infection.
Detection of coronavirus in feces historically was based on
negative-stain electron microscopy and antigen-capture ELISA
(Davis et al., 2000; Guy et al., 2000). These types of tests have not
subsequently been evaluated for ECoV detection as analytical
sensitivity and limits of detection are likely to be poorer than the
more sensitive molecular tests. Similarly, isolation of ECoV in cell
culture is difficult and time consuming, and is not recommended
for diagnostic purposes (Guy et al., 2000; Oue et al., 2011).
Sensitive laboratory diagnosis of ECoV is possible through fecal
reverse transcription qPCR. The kinetics of viral shedding in feces
from experimentally infected horses showed onset at 3–4 days,
continuing until 12–14 days post-infection (Nemoto et al., 2014);
peak shedding followed 3–4 days after the development of clinical
signs (Fig. 3). In naturally-infected horses, detectable ECoV
shedding by qPCR can last for 3–25 days (Pusterla et al., 2013;
Fielding et al., 2015).
A correlation between high viral load and mortality has recently
been reported for ECoV (Fielding et al., 2015). In SARS-CoV
infections, patient survival during acute disease is correlated with
viral load (Hung et al., 2009). One factor affecting viral load is the
ability of individuals to express genes involved in inflammation
and innate immunity (Chen et al., 2006). Variations in viral load
can also be influenced by the coronavirus strain. The replication
capability of feline coronavirus (FCoV) provides good evidence of
its effect on virulence (Chang et al., 2012). The benign feline enteric
coronavirus (FECV) genotype has low replication competency in
enterocytes, but FCoV also has a highly virulent feline infectious
peritonitis (FIP) virus (FIPV) genotype with an enhanced ability to
replicate in different cell populations. A single point mutation on
the spike gene of the different FCoV genotypes has been linked to
the changes in cell tropism, replication potential and clinical
manifestations (Chang et al., 2012).
Post-mortem diagnosis of ECoV can be achieved by qPCR on
feces or small intestinal contents collected at post-mortem
examination. Small intestinal tissue can also be tested for the
presence of ECoV by immunochemistry and direct fluorescent
antibody testing using BCoV reagents (Giannitti et al., 2015).
Pathogenesis
ECoV may be detected in both healthy foals and foals with
diarrhea; however, of the two major studies documenting this,
there is a difference in results from two different geographic
regions. Surprisingly, in the Hidaka district of Hokkaido, all
337 rectal swabs from foals with diarrhea were negative for ECoV
by qPCR, while 3/120 (2.5%) fecal swabs from healthy foals were
positive for ECoV. This study is in contrast to a study performed in
Central Kentucky, where ECoV was detected at a similar frequency
in feces of both healthy and diarrheic foals (Slovis et al., 2014). The
difference between healthy and clinically-affected animals was
that, from the panel of infectious agents tested, healthy foals
usually (except for one) only showed infection with ECoV, whilst
Fig. 3. Diagram showing temporal clinical signs and fecal shedding of equine coronavirus (ECoV) in an adult horse presented to a referring hospital because of anorexia,
lethargy and fever.
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associated with co-infections (Slovis et al., 2014). An ECoV
infection in a foal may predispose the animal to a secondary
infection with other enteric pathogens, as shown for other
coronaviruses (Pakpinyo et al., 2003; Srikumaran et al., 2007;
Brockmeier et al., 2008).
However, in clinically-affected adult horses, the predominant
infection pattern is of ECoV alone. This suggests that the infected
animal’s age influences the pathogenicity of ECoV, perhaps due to
differences in immunological responses between foals and adult
horses, or the presence of protective maternally-derived anti-
bodies in foals. Age-related patterns of disease have been reported
for FCoV, where most FIP cases occur in cats younger than 2 years
of age and protracted dry cases tend to occur in older cats. The
clinical outcome of the infection is affected by the development of
humoral, cell-mediated or mixed immune responses against theFig. 4. (a) Histological section of jejunum from an adult horse with equine coronavirus (E
by attenuated epithelium and contain sloughed necrotic enterocytes. The lamina propria 
venules in the mucosa and submucosa are occluded by fibrin thrombi. Haematoxylin
counterstain on a histological section of jejunum from an adult horse with ECoV infection
deep in the crypts. Scale bar = 200 mm.highly virulent FIPV genotype of FCoV. Interestingly, severe
suppression of natural killer cells and T regulatory cells is
correlated with clinical outcome, confirming reports that fatal
FIPV infection is associated with a weakened cell-mediated
immune response (Vermeulen et al., 2013).
Giannitti et al. (2015) has recently described the pathology of
ECoV in three adult equids. These infected animals displayed
severe diffuse necrotizing enteritis, with marked villus attenua-
tion, epithelial cell necrosis in the tips of the villi, neutrophilic and
fibrin extravasation into the small intestinal lumen (pseudomem-
brane formation), as well as crypt necrosis, microthrombosis and
hemorrhage (Fig. 4a). ECoV was detected by RT-qPCR in small
intestinal tissue, gastrointestinal contents and/or feces, and
coronavirus antigen was detected by immunohistochemistry
and/or direct fluorescent antibody testing in the small intestine
of all cases (Fig. 4b).CoV) infection. There is loss of crypts and the few remaining crypts are dilated, lined
and superficial submucosa are expanded by inflammatory infiltrates. Capillaries and
 and eosin. (b) Immunohistochemistry for bovine coronavirus with hematoxylin
. Strong granular/globular immunoreactivity is seen in the cytoplasm of enterocytes
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Most horses with ECoV infections require no to minimal
supportive treatment, as they are self-limiting. However, when
clinical signs persist for longer than 24 h, affected horses should be
treated with non-steroidal anti-inflammatory drugs (NSAIDS), as
long as their hydration status is believed to be normal. NSAIDS are
known to have adverse effects on the equine intestine and this
should be taken into consideration before these drugs are used.
Horses with more severe signs, such as diarrhea and/or colic,
should be treated more intensively with parenteral or enteral fluids
and electrolytes. In horses developing signs of endotoxemia and/or
septicemia secondary to disruption of the gastrointestinal barrier,
antimicrobial agents and gastrointestinal protectants should be
considered. While hyperammonemia-associated encephalopathy
only occurs in a small percentage of horses with ECoV infection,
early recognition and treatment with oral lactulose or neomycin
sulfate is associated with a positive outcome (N. Pusterla,
unpublished data).
There is no licensed vaccine against ECoV, although the virus is
closely related to BCoV, against which modified-live vaccines are
available that are routinely used in cattle for the prevention of
winter dysentery (Welter, 1998). The use of BCoV vaccines for the
prevention of ECoV in horses has, to the authors’ knowledge, not
been investigated for safety or efficacy.
Biosecurity recommendations
Routine management practices aimed at reducing the chances
of introducing and disseminating ECoV into premises (boarding
facilities, showground or veterinary hospitals) should be imple-
mented. Any horse developing or presenting with fever (38.5 C),
anorexia and lethargy, with or without enteric signs (colic,
diarrhea), should be strictly isolated until a laboratory diagnosis
is made. If ECoV infection is confirmed by qPCR, isolation
procedures should continue and secondary quarantine of the
source stable should be put in place. Post-infection testing of
clinical cases should be undertaken to prevent viral spread to other
horses. All new arrivals onto stables and farms should ideally be
isolated for at least 3 weeks.
Strict biosecurity measures include the use of foot-baths, and
personal protective equipment, which must be adequately
maintained for sanitary purposes. Grooms and other personnel
should work with the infected/possibly infected animals last in the
course of their daily routine. Infected horses should be exercised
when other horses are not present in the training areas, and riders
should wear protective clothing, and clean and disinfect their
boots, tack and hands after contact with these animals. Depending
on specific circumstances, horses returning from shows or
extended traveling events should be isolated. All horse vans and
trailers should be thoroughly cleaned and disinfected after use.
Common disinfectants inactivate ECoV. The most effective tool in
determining possible sources of virus introduction remains the
examination of at-risk horses for clinical signs of disease, including
twice daily assessment of rectal temperature.
Conclusions
Equine coronavirus (ECoV) has been recognized recently in
Japan, Europe and the USA as a new, clinically important, enteric
virus of adult horses. There are increasing reports of the disease,
arising from increased awareness in the field and the availability of
diagnostic tests for detecting ECoV in feces of affected horses.
Clinical signs are relatively non-specific; however hematological
findings are consistent with a viral infection and generally are
characterized by lymphopenia and neutropenia. Laboratorydiagnosis of ECoV infection is now made by the detection of ECoV
in feces by qPCR. The epidemiology, pathogenesis and prevention
of ECoV infection in horses is now being actively investigated.
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